The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer

David Cibula, Richard Pötter, François Planchamp, Elisabeth Avall-Lundqvist, Daniela Fischerova, Christine Haie Meder, Christhardt Köhler, Sigurd Lax, Jacob Christian Lindegaard, Umesh Mahantshetty, Patrice Mathevet, W Glenn McCluggage, Mary McCormack, Raj Naik, Remi Nout, Sandro Pignata, Jordi Ponce, Denis Querleu, Alexandros Rodolakis, Karl TamussinoPauline Wimberger, Maria Rosaria Raspollini

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer.

OBJECTIVE: The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide.

METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives.

RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.

Original languageEnglish
JournalRadiotherapy and Oncology
DOIs
Publication statusPublished - 2018

Fingerprint

Uterine Cervical Neoplasms
Radiotherapy
Guidelines
Pathology
Patient Advocacy
Quality of Health Care
Hysterectomy
Fertility
Publications
Consensus
Research Personnel
Pregnancy
Mortality
Incidence
Therapeutics
Research
Neoplasms

Cite this

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. / Cibula, David; Pötter, Richard; Planchamp, François; Avall-Lundqvist, Elisabeth; Fischerova, Daniela; Haie Meder, Christine; Köhler, Christhardt; Lax, Sigurd; Lindegaard, Jacob Christian; Mahantshetty, Umesh; Mathevet, Patrice; McCluggage, W Glenn; McCormack, Mary; Naik, Raj; Nout, Remi; Pignata, Sandro; Ponce, Jordi; Querleu, Denis; Rodolakis, Alexandros; Tamussino, Karl; Wimberger, Pauline; Raspollini, Maria Rosaria.

In: Radiotherapy and Oncology, 2018.

Research output: Contribution to journalArticle

Cibula, D, Pötter, R, Planchamp, F, Avall-Lundqvist, E, Fischerova, D, Haie Meder, C, Köhler, C, Lax, S, Lindegaard, JC, Mahantshetty, U, Mathevet, P, McCluggage, WG, McCormack, M, Naik, R, Nout, R, Pignata, S, Ponce, J, Querleu, D, Rodolakis, A, Tamussino, K, Wimberger, P & Raspollini, MR 2018, 'The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer', Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2018.03.003
Cibula, David ; Pötter, Richard ; Planchamp, François ; Avall-Lundqvist, Elisabeth ; Fischerova, Daniela ; Haie Meder, Christine ; Köhler, Christhardt ; Lax, Sigurd ; Lindegaard, Jacob Christian ; Mahantshetty, Umesh ; Mathevet, Patrice ; McCluggage, W Glenn ; McCormack, Mary ; Naik, Raj ; Nout, Remi ; Pignata, Sandro ; Ponce, Jordi ; Querleu, Denis ; Rodolakis, Alexandros ; Tamussino, Karl ; Wimberger, Pauline ; Raspollini, Maria Rosaria. / The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. In: Radiotherapy and Oncology. 2018.
@article{81c324e9ebf64ce0a9d3cb52190859a8,
title = "The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer",
abstract = "BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer.OBJECTIVE: The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide.METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives.RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.",
author = "David Cibula and Richard P{\"o}tter and Fran{\cc}ois Planchamp and Elisabeth Avall-Lundqvist and Daniela Fischerova and {Haie Meder}, Christine and Christhardt K{\"o}hler and Sigurd Lax and Lindegaard, {Jacob Christian} and Umesh Mahantshetty and Patrice Mathevet and McCluggage, {W Glenn} and Mary McCormack and Raj Naik and Remi Nout and Sandro Pignata and Jordi Ponce and Denis Querleu and Alexandros Rodolakis and Karl Tamussino and Pauline Wimberger and Raspollini, {Maria Rosaria}",
note = "Copyright {\circledC} 2018 European Society for Gynaecological Oncology, European Society for Radiotherapy and Oncology, and the European Society of Pathology. Published by Elsevier B.V. All rights reserved.",
year = "2018",
doi = "10.1016/j.radonc.2018.03.003",
language = "English",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer

AU - Cibula, David

AU - Pötter, Richard

AU - Planchamp, François

AU - Avall-Lundqvist, Elisabeth

AU - Fischerova, Daniela

AU - Haie Meder, Christine

AU - Köhler, Christhardt

AU - Lax, Sigurd

AU - Lindegaard, Jacob Christian

AU - Mahantshetty, Umesh

AU - Mathevet, Patrice

AU - McCluggage, W Glenn

AU - McCormack, Mary

AU - Naik, Raj

AU - Nout, Remi

AU - Pignata, Sandro

AU - Ponce, Jordi

AU - Querleu, Denis

AU - Rodolakis, Alexandros

AU - Tamussino, Karl

AU - Wimberger, Pauline

AU - Raspollini, Maria Rosaria

N1 - Copyright © 2018 European Society for Gynaecological Oncology, European Society for Radiotherapy and Oncology, and the European Society of Pathology. Published by Elsevier B.V. All rights reserved.

PY - 2018

Y1 - 2018

N2 - BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer.OBJECTIVE: The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide.METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives.RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.

AB - BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer.OBJECTIVE: The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide.METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives.RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.

U2 - 10.1016/j.radonc.2018.03.003

DO - 10.1016/j.radonc.2018.03.003

M3 - Article

C2 - 29728273

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

ER -